Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark. / Jensen, Allan; Rank, Fritz; Dyreborg, Uffe; Severinsen, Niels; Nielsen, Susanne; Lynge, Elsebeth; Vejborg, Ilse.

In: Acta Pathologica Microbiologica et Immunologica Scandinavica, Vol. 114, No. 12, 2006, p. 884-92.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jensen, A, Rank, F, Dyreborg, U, Severinsen, N, Nielsen, S, Lynge, E & Vejborg, I 2006, 'Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark.', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 114, no. 12, pp. 884-92. https://doi.org/10.1111/j.1600-0463.2006.apm_408.x

APA

Jensen, A., Rank, F., Dyreborg, U., Severinsen, N., Nielsen, S., Lynge, E., & Vejborg, I. (2006). Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark. Acta Pathologica Microbiologica et Immunologica Scandinavica, 114(12), 884-92. https://doi.org/10.1111/j.1600-0463.2006.apm_408.x

Vancouver

Jensen A, Rank F, Dyreborg U, Severinsen N, Nielsen S, Lynge E et al. Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark. Acta Pathologica Microbiologica et Immunologica Scandinavica. 2006;114(12):884-92. https://doi.org/10.1111/j.1600-0463.2006.apm_408.x

Author

Jensen, Allan ; Rank, Fritz ; Dyreborg, Uffe ; Severinsen, Niels ; Nielsen, Susanne ; Lynge, Elsebeth ; Vejborg, Ilse. / Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark. In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 2006 ; Vol. 114, No. 12. pp. 884-92.

Bibtex

@article{c2287f10b24e11ddb04f000ea68e967b,
title = "Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark.",
abstract = "Clinical mammography and needle biopsy are key tools for non-operative assessment of breast lesions. We evaluated the performance of all combined tests undertaken in Denmark in 2000. Clinical mammography and needle biopsy data were collected and linked to final cancer outcome, to determine sensitivity, specificity, and predictive values of clinical mammography, needle biopsy, and combined test. In 2000, 6709 combined tests were performed in 36 mammography clinics in Denmark. The combined test was consistently more sensitive than any single test, increasing the proportion of women correctly identified with breast cancer by 9{\%} compared with clinical mammography alone. For concordant combined tests (i.e. either both benign or both malignant), specificity and positive predictive value were 100{\%}, sensitivity was 99.1{\%}, and positive predictive value was 99.6{\%}. Therefore, Danish patients with a malignant concordant combined test can proceed directly to definitive surgery without fear of a false-positive diagnosis, and Danish women with a concordant benign combined test can omit surgery without fear of a false-negative diagnosis. In discordant cases, our results showed that any of the two tests with a suspicious or malignant result indicated a high risk of cancer, and excisional diagnostic biopsy therefore still has an important role to play.",
author = "Allan Jensen and Fritz Rank and Uffe Dyreborg and Niels Severinsen and Susanne Nielsen and Elsebeth Lynge and Ilse Vejborg",
note = "Keywords: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Breast Neoplasms; Cohort Studies; Denmark; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity",
year = "2006",
doi = "10.1111/j.1600-0463.2006.apm_408.x",
language = "English",
volume = "114",
pages = "884--92",
journal = "A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica",
issn = "0903-4641",
publisher = "Wiley Online",
number = "12",

}

RIS

TY - JOUR

T1 - Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark.

AU - Jensen, Allan

AU - Rank, Fritz

AU - Dyreborg, Uffe

AU - Severinsen, Niels

AU - Nielsen, Susanne

AU - Lynge, Elsebeth

AU - Vejborg, Ilse

N1 - Keywords: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Breast Neoplasms; Cohort Studies; Denmark; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity

PY - 2006

Y1 - 2006

N2 - Clinical mammography and needle biopsy are key tools for non-operative assessment of breast lesions. We evaluated the performance of all combined tests undertaken in Denmark in 2000. Clinical mammography and needle biopsy data were collected and linked to final cancer outcome, to determine sensitivity, specificity, and predictive values of clinical mammography, needle biopsy, and combined test. In 2000, 6709 combined tests were performed in 36 mammography clinics in Denmark. The combined test was consistently more sensitive than any single test, increasing the proportion of women correctly identified with breast cancer by 9% compared with clinical mammography alone. For concordant combined tests (i.e. either both benign or both malignant), specificity and positive predictive value were 100%, sensitivity was 99.1%, and positive predictive value was 99.6%. Therefore, Danish patients with a malignant concordant combined test can proceed directly to definitive surgery without fear of a false-positive diagnosis, and Danish women with a concordant benign combined test can omit surgery without fear of a false-negative diagnosis. In discordant cases, our results showed that any of the two tests with a suspicious or malignant result indicated a high risk of cancer, and excisional diagnostic biopsy therefore still has an important role to play.

AB - Clinical mammography and needle biopsy are key tools for non-operative assessment of breast lesions. We evaluated the performance of all combined tests undertaken in Denmark in 2000. Clinical mammography and needle biopsy data were collected and linked to final cancer outcome, to determine sensitivity, specificity, and predictive values of clinical mammography, needle biopsy, and combined test. In 2000, 6709 combined tests were performed in 36 mammography clinics in Denmark. The combined test was consistently more sensitive than any single test, increasing the proportion of women correctly identified with breast cancer by 9% compared with clinical mammography alone. For concordant combined tests (i.e. either both benign or both malignant), specificity and positive predictive value were 100%, sensitivity was 99.1%, and positive predictive value was 99.6%. Therefore, Danish patients with a malignant concordant combined test can proceed directly to definitive surgery without fear of a false-positive diagnosis, and Danish women with a concordant benign combined test can omit surgery without fear of a false-negative diagnosis. In discordant cases, our results showed that any of the two tests with a suspicious or malignant result indicated a high risk of cancer, and excisional diagnostic biopsy therefore still has an important role to play.

U2 - 10.1111/j.1600-0463.2006.apm_408.x

DO - 10.1111/j.1600-0463.2006.apm_408.x

M3 - Journal article

C2 - 17207089

VL - 114

SP - 884

EP - 892

JO - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

JF - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

SN - 0903-4641

IS - 12

ER -

ID: 8592388